Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 126 |
SGTX
126
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| – | – | – | – |
|
| 127 |
SIOX
127
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| – | – | – | – |
|
| 128 |
SLBT
128
SL Science Holding Ltd
SLBT
$869M
| – | – | – | – |
|
| 129 |
SQZ
129
DELISTED
SQZ Biotechnologies Company
SQZ
| – | – | – | – |
|
| 130 |
TCRR
130
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| – | – | – | – |
|
| 131 |
131
DELISTED
2seventy bio
TSVT
| – | – | – | – |
|